Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial for FX006

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. RTB
6. ONON
7. AAPL
8. AZN
9. SPCX
10. TRMD

Go back to Flexion Therapeutics Reports Top-Line Data From Pivotal Phase 2b Clinical Trial for FX006
FLEXION THERAPEUT (NYSE: FLXN) Delayed: 24.61 -0.05 (0.2%)
Previous Close $24.66    52 Week High $23.57 
Open $24.60    52 Week Low $7.56 
Day High $24.64    P/E N/A 
Day Low $24.58    EPS $-2.04 
Volume 5,368